Study finds subtle brain damage in some HIV patients on drug therapy
Researchers have found subtle damage in the brains of HIV-positive patients whose viral load is effectively suppressed by anti-retroviral therapy.
University of California San Francisco
Displaying 15901 - 15930 of 16427
-
-
Clinical trial shows improved survival for a severe birth defect -- with or without fetal surgery
Newborns with a severe birth defect that hampers lung growth have ...
-
Ronnie Lott shares the spotlight
When you see Ronnie Lott hunker down to chat with a hospitalized child, it's immediately clear why he and his wife, Karen founded a charity to help children.
-
Sexual and physical assault are common experiences for the homeless, according to a UCSF study
Homeless people are at high risk of being victims of sexual or physical assault, according to UCSF researchers.
-
New leader for Center for Consumer Self Care at UCSF
The UCSF Center for Consumer Self Care has appointed a new leader. R. William Soller, PhD, former leading regulatory scientist and health policy advocate for the Consumer Healthcare Products Association, is the new executive director of the Center in the UCSF School of Pharmacy.
-
1,800 San Francisco teachers invited to huge UCSF lab supplies give-away
When UCSF faculty moved their laboratories from the UCSF Parnassus campus to the new UCSF Mission Bay campus earlier this year, they earmarked surplus equipment and supplies for public schools.
-
Macy's West selects UCSF Children's Hospital as the beneficiary of its annual San Francisco holiday
For the first time, Macy's West is making its annual Union Square holiday tree lighting a charitable event, benefiting UCSF Children's Hospital.
-
Paul Volberding assumes leadership role at HIV medicine association
Paul Volberding, MD, vice chair of University of California, San Francisco's Department of Medicine and chief of medical service at the San Francisco VA Medical Center, has assumed the position of chairman of the board of directors of the HIV Medicine Association (HIVMA).
-
$35 Million Gift Supports Construction of Helen Diller Family Cancer Research Building
A gift of $35 million--the largest contribution from individual donors in UCSF history--has been made by the Helen Diller Family to support construction of a new cancer research building at UCSF Mission Bay.
-
UCSF to dedicate Mission Bay
UCSF will officially launch its new UCSF Mission Bay Campus with a festive celebration and dedication ceremony on Tuesday, October 28.
-
UCSF School of Dentistry receives major award to study Sjogren's syndrome
The UCSF School of Dentistry has received a five-year $11.9 million award to establish an international registry network to study Sjögren's (SHOW grens) syndrome, an immulogic disorder.
-
Common drug, administered promptly, reduces incidence of post-traumatic stress disorder (ptsd), small study finds
A common drug administered in the first hours following trauma to patients deemed to be at risk of developing post-traumatic stress disorder (PTSD) reduced the occurrence of PTSD, according to a study led by researchers at the University of Lille, France.
-
US doctors perform more than twice as many surgical biopsies to find the same number of breast cancer
Although the rate of breast cancer detection is similar in the two countries, US doctors perform two to three times more open surgical biopsies than British doctors.
-
Rates of early kidney disease equal between black and white Americans, but blacks five times as likely to progress to kidney failure
It's long been known that black Americans are four to five times as likely as white Americans to suffer from kidney disease that is severe enough to require dialysis or transplantation.
-
UCSF Testing Medical Marijuana for Cancer Pain
UCSF researchers are conducting a study to determine if it is safe and effective to use smoked marijuana in combination with opioid pain medications to treat cancer pain.
-
UCSF vascular surgeons develop new technique to repair aortic arch aneurysm
A novel treatment developed by UCSF vascular surgeons has been used in a first-of-its-kind operation to repair a life-threatening aneurysm in the patient's aortic arch, which carries blood from the heart.
-
Proteomics advance: scientists determine identity, cell locale and quantity of nearly all proteins
UCSF scientists have developed a set of powerful tools that allow researchers to look in unprecedented detail at the full complement of thousands of proteins acting and interacting in a living organism.
-
Many women can safely extend cervical cancer screening interval to three years
Many women can safely extend their cervical cancer screening interval to three years, according to a new study published in The New England Journal of Medicine.
-
New Bay Area center will unite local experts in breast cancer research
A new federally funded Bay Area center will bring together local health experts to investigate possible environmental links to breast cancer and the high incidence of the disease in some regional counties.
-
Study raises doubts about ability of bone marrow-derived adult stem cells to differentiate in heart
A study led by UCSF investigators indicates that bone marrow-derived cells from mice that are transplanted into other mice fuse with cells in the animals' heart, brain and liver, and take on their characteristics.
-
Airline infant safety seat rule could cause more deaths than it prevents, pediatricians say
A proposed Federal Aviation Administration (FAA) regulation that would require infant restraint seats for children under age two would likely lead to more deaths in automobile crashes than the deaths prevented in air crashes
-
HIV's assault on immune system
A UCSF-Gladstone Institute of Virology and Immunology (GIVI) Center for AIDS Research (CFAR) symposium titled, Immunology of HIV Infection will take place October 22 and 23, 2003.
-
New UCSF-based center will
A new federally funded Center, based at UCSF, will bring together local health experts to investigate possible environmental links to breast cancer and the high incidence of disease in the Bay Area.
-
Progress reported on diabetes, aging and childhood disease research
Top California scientists will report progress this week on studies of Alzheimer's Disease and other diseases of aging, as well as efforts to extend lifespan, develop cures for diabetes and improve diagnosis and treatment of childhood neurological disorders.
-
UCSF arthritis and joint replacement center will deliver comprehensive care
UCSF has opened a new Arthritis and Joint Replacement Center -- a joint effort between the departments of rheumatology and orthopedic surgery.
-
Scientists switch components in cell circuits: possible new technology, therapy
By tinkering with a few of the parts in a vital signaling circuit found in human cells, UCSF scientists have demonstrated the possibility of an entirely new technology: developing new devices or therapies by mixing and matching sub-cellular signaling components.
-
Combining osteoporosis drugs produces no added benefit
Combining two types of drugs prescribed for osteoporosis does not produce a synergistic benefit in treating the disease, according to a study headed by a UCSF researcher.
-
Researchers now on road to isolating skin stem cells
Researchers at the San Francisco VA Medical Center (SFVAMC) have taken the first major step toward isolating adult stem cells from mouse skin, having developed a test that confirms the presence and number of stem cells in a given amount of tissue.
-
UCSF begins study testing antiviral drug tenofovir to prevent HIV infection
UCSF researchers have been funded by the National Institutes of Health to study the antiretroviral drug tenofovir as a potential pre-exposure prophylaxis in Cambodia among high-risk, HIV-uninfected women.
-
Pancreatic cancer linked to developmental cell signaling pathway
Scientists at UCSF and Massachusetts General Hospital (MGH) have found strong evidence that a cell signaling pathway active in embryonic development plays a crucial role in pancreatic cancer.